MEDICASA
The computed 12-month bankruptcy probability of MEDICASA is 0.2% (very low). The 2024 annual accounts show equity of €70k and a net result of €67k. Equity is growing by ~128.5% per year across the filed fiscal years. Its solvency ranks better than 16% of 6573 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €70k |
| Net result | €67k |
| Staff (FTE) | 1 |
| Better than sector | 16% |
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 17.5% | 66.7% | |
| Net result | €67k | €46k | |
| Equity | €70k | €79k | |
| Gross operating margin | €133k | €78k | |
| Staff costs | €27k | €21k |
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €100k |
| Net profit | €67k |
| Cash flow | €80k |
| Staff costs | €27k |
| Income taxes | €16k |
| Dividends | - |
| Total assets | €400k |
| Equity | €70k |
| Debt | €330k |
| of which ≤ 1y | €95k |
| of which > 1y | €235k |
| Working capital | €-43k |
| Employees (FTE) | 1.0 |
| 2024 | |
|---|---|
| Current ratio | 0.54 |
| Quick ratio | 0.54 |
| Working capital ratio | -10.9% |
| Solvency | 17.5% |
| Debt / equity | 4.71 |
| Long-term debt ratio | 3.35 |
| Interest coverage | 22.06 |
| Gross margin | - |
| Net margin | - |
| ROA | 16.7% |
| ROE | 95.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €400k |
| Fixed assets | 21/28 | €348k |
| Tangible fixed assets | 22/27 | €348k |
| Current assets | 29/58 | €51k |
| Amounts receivable within one year | 40/41 | €5k |
| Cash & bank | 54/58 | €45k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €400k |
| Equity | 10/15 | €70k |
| Contributions / capital | 10/11 | €10k |
| Accumulated profits (losses) | 14 | €60k |
| Amounts payable | 17/49 | €330k |
| Amounts payable after one year | 17 | €235k |
| Amounts payable within one year | 42/48 | €95k |
| Trade debts payable within one year | 44 | €1k |
| Income statement | ||
| Gross operating margin | 9900 | €133k |
| Operating result | 9901 | €87k |
| Financial charges | 65 | €5k |
| Result before taxes | 9903 | €82k |
| Income taxes | 67/77 | €16k |
| Net result for the period | 9904 | €67k |
| Result to be appropriated | 9905 | €67k |
Former directors (1)
-
Caroline StiévenartDirectorState Gazette act 24182228 (31-12-2024)Former- → 14-10-2024
| NACE primary | Activiteiten van huisartspraktijken(86210) |
| Legal form | Private limited company(610) |
| Incorporation | 07-10-2021 |
| Status | Active |
| Postal code | 6060 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52026C0344/00D000 | Wallonia | 397 m² | 1 · 86 m² | 15.7 m · 5 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
31-12-2024 Caroline Stiévenart resigns as director
- Caroline Stiévenart, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Caroline Sti\u00E9venart",
"address": "6230 Pont-\u00E0-Celles rue Notre Dame des Gr\u00E2ces, 48",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "personal",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-10-14",
"evidence_quote": "Madame Caroline Sti\u00E9venart, domicili\u00E9e \u00E0 6230 Pont-\u00E0-Celles rue Notre Dame des Gr\u00E2ces, 48 a d\u00E9missionn\u00E9e de ses fonctions d\u0027administrateur avec effet r\u00E9troactif au 14 octobre 2024 pour raisons personnelles.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "retroactive"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-12-31",
"filing_date": "2024-12-18",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-12-14",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0775.482.435",
"name_full": "MEDICASA",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "VAN DE STEENE Sa\u00EFdja",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | MEDICASA |